This protocol is judged by an institutional assessment board, an impartial team that testimonials any scientific trials involving humans. If a review requires a Schedule I drug, once the board approves the protocol as ethical, the researchers must make an application for an investigational new drug (IND) number from the FDA.Along with the doses pa